pubmed-article:9779717 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C0023418 | lld:lifeskim |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C0205851 | lld:lifeskim |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C0332154 | lld:lifeskim |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:9779717 | lifeskim:mentions | umls-concept:C1511559 | lld:lifeskim |
pubmed-article:9779717 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:9779717 | pubmed:dateCreated | 1998-10-26 | lld:pubmed |
pubmed-article:9779717 | pubmed:abstractText | High cumulative epipodophyllotoxin dosages are reported to be associated with an elevated risk for secondary acute myeloid leukemia (s-AML). This study examined the risk of s-AML following cumulative etoposide doses greater than 2 g/m2 in patients with metastatic germ cell tumors (GCT). | lld:pubmed |
pubmed-article:9779717 | pubmed:language | eng | lld:pubmed |
pubmed-article:9779717 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9779717 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9779717 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9779717 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9779717 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9779717 | pubmed:month | Oct | lld:pubmed |
pubmed-article:9779717 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:BeyerJJ | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:BironPP | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:DrozJ PJP | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:SchmollH JHJ | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:BokemeyerCC | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:KanzLL | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:HarstrickAA | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:SchöffskiPP | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:HartmannJ TJT | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:KuczykMM | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:Kollmannsberg... | lld:pubmed |
pubmed-article:9779717 | pubmed:author | pubmed-author:FléchonAA | lld:pubmed |
pubmed-article:9779717 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9779717 | pubmed:volume | 16 | lld:pubmed |
pubmed-article:9779717 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9779717 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9779717 | pubmed:pagination | 3386-91 | lld:pubmed |
pubmed-article:9779717 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:meshHeading | pubmed-meshheading:9779717-... | lld:pubmed |
pubmed-article:9779717 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9779717 | pubmed:articleTitle | Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. | lld:pubmed |
pubmed-article:9779717 | pubmed:affiliation | Department of Hematology/Oncology, University of Tuebingen Medical Center, Germany. | lld:pubmed |
pubmed-article:9779717 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9779717 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779717 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779717 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779717 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779717 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9779717 | lld:pubmed |